Hold FDA accountable for placing abortion advocacy above women’s health

NEWYou can now listen to Fox News articles!

I’ll never forget the day that I spoke to Monty, the father of a young woman, Holly, who had died as the result of chemical abortion at the age of 18. She had graduated from high school a few months earlier and went to a local Planned Parenthood for the abortion drugs.

She died of septic shock a few weeks later.

Monty, a man who identified as being "pro-choice," told me that he wanted to do everything possible to teach people about the dangers of chemical abortion.

The sad reality is that chemical abortions – or abortion drugs – are much harder on women’s health and present many health complications. In fact, the Food and Drug Administration's label for abortion drugs warns that roughly one in 25 women taking the drugs will end up in the emergency room.

CHEMICAL ABORTION HARMS WOMEN. SUPREME COURT CAN'T IGNORE THEM

Soon oral arguments will happen at the Supreme Court in the case FDA v. Alliance for Hippocratic Medicine, in which the court will examine whether the Food and Drug Administration has failed to do the very job it was created for, to protect the public’s health by ensuring the safety and efficacy of drugs.

I would argue that the FDA is doing a profound disservice to women and girls everywhere in the name of abortion.

In 2000, when the FDA first approved the use of abortion drugs – the combined regimen of mifepristone and misoprostol – to terminate a pregnancy, they instituted safety standards in light of inherent risks associated with chemical abortions.

It was required that women be seen by a doctor when taking abortion drugs and that they be seen prior to and cared for during the process. This was crucial to protect the safety of the woman taking these drugs.

Addi